Screener
iRadimed IRMD Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Investing activities: | ||
| Purchases of property and equipment | (403) | (3,697) |
| Capitalized intangible assets | (66) | (220) |
| Net cash used in investing activities | (469) | (3,917) |
| Financing activities: | ||
| Dividends paid | (2,556) | (2,162) |
| Taxes paid related to the net share settlement of equity awards | (50) | (116) |
| Net cash used in financing activities | (2,606) | (2,278) |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's investing cash flow?
- iRadimed (IRMD) reported investing cash flow of -$469K in Q1 2026.
- How has iRadimed's investing cash flow changed year-over-year?
- iRadimed's investing cash flow increased by 88.0% year-over-year, from -$3.92M to -$469K.
- What is the long-term trend for iRadimed's investing cash flow?
- Over 3 years (2022 to 2025), iRadimed's investing cash flow has grown at a 79.6% compound annual growth rate (CAGR), from -$1.45M to -$8.42M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about iRadimed's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude